Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Per Guldberg

Showing results (51-60 of 102) with videos related to

Pageof 11
Sort By:
The Journal of Molecular Diagnostics : JMD|August 20, 2013
Author's reply: To PMID 23159593Lasse S Kristensen, Lise Lotte Hansen, Johanne Lade-Keller, et al.
Blood|September 28, 2002
Demethylation of a hypermethylated P15/INK4B gene in patients with myelodysplastic syndrome by 5-Aza-2'-deoxycytidine (decitabine) treatmentMichael Daskalakis, Tudung T Nguyen, Carvell Nguyen, et al.
Molecular Genetics and Metabolism|October 19, 2019
Phenylalanine hydroxylase genotype-phenotype associations in the United States: A single center studyFarrah Rajabi, Frances Rohr, Ann Wessel, et al.
British Journal of Haematology|November 12, 2005
Molecular typing of adult acute myeloid leukaemia: significance of translocations, tandem duplications, methylation, and selective gene expression profilingLene Hyldahl Olesen, Anni Aggerholm, Bodil Lind Andersen, et al.
Journal of Clinical Pathology|March 26, 2013
A role for immunohistochemical detection of BRAF V600E prior to BRAF-inhibitor treatment of malignant melanoma?Johanne Lade-Keller, Lasse Sommer Kristensen, Rikke Riber-Hansen, et al.
Scientific Reports|February 24, 2021
Screening of metabolic modulators identifies new strategies to target metabolic reprogramming in melanomaCecilie Abildgaard, Salvatore Rizza, Helle Christiansen, et al.
Oncogene|September 14, 2004
Aberrations of the Chk2 tumour suppressor in advanced urinary bladder cancerJirina Bartkova, Per Guldberg, Kirsten Grønbaek, et al.
European Urology|July 16, 2016
A Prospective Blinded Evaluation of Urine-DNA Testing for Detection of Urothelial Bladder Carcinoma in Patients with Gross HematuriaChristina M Dahmcke, Kenneth E Steven, Louise K Larsen, et al.
The Journal of Molecular Diagnostics : JMD|April 24, 2010
Custom-designed MLPA using multiple short synthetic probes: application to methylation analysis of five promoter CpG islands in tumor and urine specimens from patients with bladder cancerReza R Serizawa, Ulrik Ralfkiaer, Christina Dahl, et al.
British Journal of Haematology|November 6, 2014
Persistence of DNMT3A mutations at long-term remission in adult patients with AMLGro G Pløen, Line Nederby, Per Guldberg, et al.
Pageof 11

Showing results (51-60 of 102) with videos related to

Sort By:
Pageof 11
The Journal of Molecular Diagnostics : JMD|August 20, 2013
Author's reply: To PMID 23159593Lasse S Kristensen, Lise Lotte Hansen, Johanne Lade-Keller, et al.
Blood|September 28, 2002
Demethylation of a hypermethylated P15/INK4B gene in patients with myelodysplastic syndrome by 5-Aza-2'-deoxycytidine (decitabine) treatmentMichael Daskalakis, Tudung T Nguyen, Carvell Nguyen, et al.
Molecular Genetics and Metabolism|October 19, 2019
Phenylalanine hydroxylase genotype-phenotype associations in the United States: A single center studyFarrah Rajabi, Frances Rohr, Ann Wessel, et al.
British Journal of Haematology|November 12, 2005
Molecular typing of adult acute myeloid leukaemia: significance of translocations, tandem duplications, methylation, and selective gene expression profilingLene Hyldahl Olesen, Anni Aggerholm, Bodil Lind Andersen, et al.
Journal of Clinical Pathology|March 26, 2013
A role for immunohistochemical detection of BRAF V600E prior to BRAF-inhibitor treatment of malignant melanoma?Johanne Lade-Keller, Lasse Sommer Kristensen, Rikke Riber-Hansen, et al.
Scientific Reports|February 24, 2021
Screening of metabolic modulators identifies new strategies to target metabolic reprogramming in melanomaCecilie Abildgaard, Salvatore Rizza, Helle Christiansen, et al.
Oncogene|September 14, 2004
Aberrations of the Chk2 tumour suppressor in advanced urinary bladder cancerJirina Bartkova, Per Guldberg, Kirsten Grønbaek, et al.
European Urology|July 16, 2016
A Prospective Blinded Evaluation of Urine-DNA Testing for Detection of Urothelial Bladder Carcinoma in Patients with Gross HematuriaChristina M Dahmcke, Kenneth E Steven, Louise K Larsen, et al.
The Journal of Molecular Diagnostics : JMD|April 24, 2010
Custom-designed MLPA using multiple short synthetic probes: application to methylation analysis of five promoter CpG islands in tumor and urine specimens from patients with bladder cancerReza R Serizawa, Ulrik Ralfkiaer, Christina Dahl, et al.
British Journal of Haematology|November 6, 2014
Persistence of DNMT3A mutations at long-term remission in adult patients with AMLGro G Pløen, Line Nederby, Per Guldberg, et al.
Pageof 11